Pimozide cf. Haloperidol in Tourette Syndrome
Pimozide (3.4 mg/day) and haloperidol (3.5 mg/day) therapy for Tourette syndrome were compared in a double-blind, 24-week, placebo-controlled crossover study of 22 patients, aged 7-16 years, at the Institute of Psychiatry, Charleston, SC.
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pediatric Neurology Briefs Publishers
1997-08-01
|
| Series: | Pediatric Neurology Briefs |
| Subjects: | |
| Online Access: | https://www.pediatricneurologybriefs.com/articles/2363 |